Sign in

Ellen Richstone

Director at COGNITION THERAPEUTICS
Board

About Ellen B. Richstone

Independent director of Cognition Therapeutics since 2021; age 73. Audit Committee Chair and member of the Nominating & Corporate Governance Committee. Former CFO of public and private companies, including Fortune 500 Rohr Aerospace; NACD Certified Director (2024) and designated audit committee financial expert. Education: Scripps College; graduate degrees from the Fletcher School (Tufts); Advanced Professional Certificate in Finance (NYU); executive program (Cornell). Recognitions include NACD Leadership Fellow and Corporate Directors Group Distinguished Director Award (2013) .

Past Roles

OrganizationRoleTenureCommittees/Impact
Rohr Aerospace (Fortune 500)Chief Financial Officer1989–2012 (CFO roles across several companies)Senior finance leadership; public company reporting
Entrepreneurial Resources GroupPresident & CEO2002–2004Led operations and strategy
American Power Conversion (S&P 500)Director; Board financial expert2004–2007 (until sale)Financial expert designation; oversight of sale process

External Roles

OrganizationRoleTenureNotes
Superior Industries International (NYSE: SUP)DirectorSince Oct 2016Current public company directorship
Orion Energy Systems (NASDAQ: OESX)DirectorSince May 2017Current public company directorship
eMagin CorporationDirectorJul 2014–Oct 2023Prior public board
BioAmberDirectorMay 2014–Nov 2018Prior public board
NACD New EnglandDirector (non-profit)N/AGovernance thought leadership

Board Governance

  • Independence: Independent director; Board comprises 5 independent directors; independent committees; regular executive sessions .
  • Committees: Audit (Chair); Nominating & Corporate Governance (Member). Designated audit committee financial expert .
  • Attendance: 2024—Board held 11 meetings; Audit 4; NCGC 3; each director attended all committee meetings served and at least 75% of Board meetings .
  • Election results (June 18, 2025): Re-elected as Class I director (term to 2028) with 8,686,877 For; 2,470,562 Withheld; 22,760,336 Broker Non-Votes .

Fixed Compensation

Component (FY 2024)Amount
Cash fees earned$57,750
Director equity—Stock awards (grant-date fair value)$16,575
Director equity—Option awards (grant-date fair value)$13,064
Total$87,389

Non-Employee Director Compensation Policy (amended Feb 14, 2024):

  • Cash retainers: Annual $40,000; Audit Chair $15,000; NCGC Chair $8,000; Audit Member $7,500; Compensation Member $7,500; NCGC Member $4,000 .
  • Equity: Annual option to purchase 8,500 shares and 8,500 RSUs (amended from 6,000 each); vest on first to occur of June 7, 2025 or date of 2025 annual meeting; initial grants 11,500 options + 11,500 RSUs at onboarding .

Performance Compensation

Equity Award TypeShares Granted (2024 Annual)Vesting ScheduleNotes
RSUs8,500Vest on first to occur of June 7, 2025 or 2025 annual meeting dateTime-based; no performance metrics disclosed
Stock Options8,500Vest on same scheduleTime-based; grant-date FV included above

No director performance metrics (e.g., TSR, EBITDA) tied to compensation for non-employee directors are disclosed; awards are time-based .

Other Directorships & Interlocks

CompanyOverlap/Interlock with CGTXPotential Conflict Notes
Superior Industries (SUP)None disclosedManufacturing/automotive; no disclosed related-party transactions with CGTX
Orion Energy Systems (OESX)None disclosedEnergy/lighting; no disclosed related-party transactions with CGTX
eMagin; BioAmberNone disclosedPrior roles; no CGTX related-party transactions disclosed

Expertise & Qualifications

  • Financial expertise: Former CFO; audit committee financial expert; deep public company oversight .
  • Governance credentials: NACD Certified Director (Jan 2024); NACD Leadership Fellow; Executive Master’s Certification in director governance .
  • Education: Scripps College; graduate degrees (Fletcher School, Tufts); NYU Advanced Professional Certificate in Finance; Cornell executive program .
  • Recognition: Corporate Directors Group Distinguished Director Award (2013) .

Equity Ownership

HolderShares OwnedDerivatives/UnitsTotal Beneficial Ownership% of OutstandingNotes
Ellen B. Richstone16,000 common shares 39,505 options exercisable within 60 days; 8,500 RSUs vesting within 60 days 64,005 shares beneficially (incl. derivatives per SEC rules) <1.0% Insider policy prohibits hedging and pledging of company stock

Company insider trading policy bans hedging, shorting, options trading, margin accounts, and pledging—alignment-positive for investors .

Governance Assessment

  • Board effectiveness: Richstone chairs Audit with two independent members; designated financial expert; Audit oversees financial reporting, related-party reviews, cyber/data protection, risk and complaints—robust governance posture . Attendance and committee engagement in 2024 were strong (100% on committees; ≥75% Board) .
  • Independence & alignment: Independent director; anti-hedging/pledging policy; director equity grants and ownership provide alignment without performance distortions typical in executive pay .
  • Shareholder support: Strong re-election vote (8.69M For vs. 2.47M Withheld), indicating investor confidence; auditor ratification near-unanimous .
  • Conflicts/related-party exposure: No related-party transactions disclosed involving Richstone; Audit Committee actively reviews such matters under formal policy .
  • Compensation structure signals: Mix of cash retainers plus time-based RSU/option grants; policy caps and standardized grants reduce discretion risk; no performance metrics tied to director pay—appropriate for independence but limits pay-for-performance linkage .

RED FLAGS

  • None disclosed specific to Richstone: no pledging/hedging, no related-party transactions, no Section 16(a) delinquencies noted for her in 2024 .

Key Implications for Investors

  • As Audit Chair and financial expert, Richstone’s oversight of reporting integrity, cyber/data risk, and related-party transactions is a governance strength supporting confidence in CGTX’s controls .
  • Strong engagement and shareholder support reduce governance risk; independence and alignment policies mitigate potential conflicts .